ACC: ‘Imperfect Evidence’ Offered on Dual Antiplatelet Therapy

MedPage Today -- ATLANTA -- What is the ideal duration for dual antiplatelet therapy following treatment with a drug-eluting stent? That question has been a vexing one for cardiologists who try to balance the risk of stent thrombosis, especially very late events, against the ever present bleeding risk posed by aggressive anticoagulation therapy.